CTM
Castellum, Inc.
CTM has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CTM overall, supported by stronger fundamentals and stronger modeled upside.
CTM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Weak |
CTM's revenue and cash flow are currently stable, but its profitability and balance sheet are under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CTM PE Valuation
CTM has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
CTM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect CTM's earnings to decline, with its revenue and profitability holding steady.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
CTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.04 | +$0.02 |
| Q2 2026 | -$0.03 | +$0.05 |
| Q1 2026 | -$0.02 | +$0.09 |
| Q4 2025 | -$0.03 | +$0.15 |
| Q3 2025 | -$0.06 | +$0.12 |
| Q2 2025 | -$0.08 | +$0.27 |
| Q1 2025 | -$0.11 | +$0.25 |
| Q4 2024 | -$0.18 | +$0.20 |
CTM is still losing money, but far less than before: $0.04 per share over the past year, against $0.58 at its worst in mid-2022.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CTM in the latest year-over-year earnings comparison.
CTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.7M | +0.6% |
| Q2 2026 | $13.9M | -1.1% |
| Q1 2026 | $14.3M | +23% |
| Q4 2025 | $12.6M | +22% |
| Q3 2025 | $14.6M | +26% |
| Q2 2025 | $14M | +22% |
| Q1 2025 | $11.7M | +2.9% |
| Q4 2024 | $10.3M | -7.1% |
CTM's revenue is growing: $15M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.8% | -6.9 points |
| Q2 2026 | -7.9% | -5.2 points |
| Q1 2026 | -4.9% | +7.9 points |
| Q4 2025 | -11% | +4.7 points |
| Q3 2025 | 3% | +15 points |
| Q2 2025 | -2.7% | +11 points |
| Q1 2025 | -13% | +11 points |
| Q4 2024 | -16% | -1.9 points |
CTM's operating margin was −3.8% last quarter, down 6.9 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over CTM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CTM on profitability, with a higher operating margin.
CTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.3M | -234% |
| Q1 2026 | $1.3M | +$3.8M |
| Q4 2025 | -$671.5K | -$277.1K |
| Q3 2025 | $957K | +30% |
| Q1 2025 | -$2.5M | -10647% |
| Q4 2024 | -$394.4K | -145% |
| Q3 2024 | $738.9K | +$2M |
| Q2 2024 | $748.6K | +33% |
CTM's free cash flow has turned positive again: $366,940 over the past year, against −$1M the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over CTM on cash generation, producing positive trailing cash flow while its opponent burns cash.
CTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +138K shares |
| 1 year | +5.6% | +5.1M shares |
| 3 years | +96% | +46.5M shares |
| 5 years | +515% | +79.4M shares |
| Available history | +543% | +80.1M shares |
CTM has 95M diluted shares, up 5.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over CTM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CTM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 29.1x | High |
| Q1 2021 | 11.1x | High |
CTM's net debt is more than 20 years of its operating earnings (EBITDA).
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 14.3 | Oversold |
CTM's weekly RSI is 36 (neutral) and its Stochastic is 14 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CTM PE vs Technology Sector
CTM has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
CTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.54 | 17% below |
| 20 week MA | $0.60 | 25% below |
| 50 week MA | $0.74 | 39% below |
| 100 week MA | $0.91 | 51% below |
| 200 week MA | $0.67 | 33% below |
SNDK has stronger trend alignment. CTM is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $1.47 | $1.22 | -17% |
| 2023 | $1.22 | $0.30 | -75% |
| 2024 | $0.30 | $1.42 | +373% |
| 2025 | $1.42 | $1.03 | -27% |
| 2026 YTD | $1.03 | $0.45 | -56% |
CTM's yearly returns have swung widely, from +373% in 2024 to −75% in 2023. It's down 56% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CTM on returns for 2026, with the stronger performance.